Skip to main content

Concord Wealth Partners

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1814214 ABINGDON, VA

Position in HALO

as of Jun 30, 2026 · filed Jul 27, 2026
Position Value
$5,165
+$724 QoQ
Shares Held
66
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#599
of 664 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Concord Wealth Partners holds $158,287 across 14 Biotechnology names. HALO ranks #4 (3.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 HALO
Halozyme Therapeutics, Inc.
This page
66 $5,165

All Filings in HALO

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,165 66
2025-12-31 $4,441 66
2025-09-30 $4,840 66
2025-06-30 $3,433 66
2025-03-31 $4,211 66
2024-12-31 $3,155 66
2024-09-30 $3,777 66
2024-06-30 $3,455 66
2024-03-31 $2,684 66
2023-12-31 $2,439 66
2023-09-30 $2,521 66
2023-06-30 $2,380 66
2023-03-31 $2,520 66
2022-12-31 $3,755 66
2022-06-30 $2,904 66
2022-03-31 $2,632 66
2021-12-31 $2,653 66
2021-09-30 $2,684 66
2021-06-30 $2,997 66
2021-03-31 $2,751 66
2020-12-31 $2,818 66